{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:51:08Z","timestamp":1781945468955,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bmcl.2025.130525","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T07:18:34Z","timestamp":1766647114000},"page":"130525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and antiviral activity evaluation of the bis-ester prodrug of N4-hydroxycytidine phosphate"],"prefix":"10.1016","volume":"133","author":[{"given":"Hao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhuan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bmcl.2025.130525_bb0005","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3201\/eid2207.151990","article-title":"A literature review of zika virus","volume":"22","author":"Plourde","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130525_bb0010","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00228-20","article-title":"Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\/COVID-19 detection","volume":"34","author":"Safiabadi Tali","year":"2021","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130525_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","article-title":"Ebola virus disease","volume":"6","author":"Jacob","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bmcl.2025.130525_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2020.112752","article-title":"COVID-19 diagnosis -a review of current methods","volume":"172","author":"Y\u00fcce","year":"2021","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.bmcl.2025.130525_bb0025","article-title":"Respiratory syncytial virus infection in adults","volume":"366","author":"Nam","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130525_bb0030","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/s41467-022-28931-3","article-title":"Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins","volume":"13","author":"Hsieh","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130525_bb0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/jama.2019.20225","article-title":"New flu antiviral candidate may thwart drug resistance","volume":"323","author":"Hampton","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130525_bb0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s43856-023-00383-w","article-title":"Transporter modulation of molnupiravir and its metabolite \u03b2-D-N4-hydroxycytidine across the blood-brain barrier in a rat","volume":"3","author":"Chang","year":"2023","journal-title":"Commun Med"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130525_bb0045","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1093\/cid\/ciac199","article-title":"Pharmacokinetics of \u00df-d-N4-hydroxycytidine, the parent nucleoside of prodrug molnupiravir, in nonplasma compartments of patients with severe acute respiratory syndrome coronavirus 2 infection","volume":"75","author":"FitzGerald","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"22","key":"10.1016\/j.bmcl.2025.130525_bb0050","doi-asserted-by":"crossref","first-page":"12031","DOI":"10.1093\/nar\/gkad1002","article-title":"Uridine-cytidine kinase 2 potentiates the mutagenic influence of the antiviral \u03b2-d-N4-hydroxycytidine","volume":"51","author":"Xu","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2025.130525_bb0055","series-title":"N4-hydroxycytidine and derivatives and antiviral uses related thereto","author":"Painter","year":"2017"},{"key":"10.1016\/j.bmcl.2025.130525_bb0060","unstructured":"N4-hydroxycytidine phosphate prodrug and its preparation method and application. CN Patent 116554249 B, 2024."},{"key":"10.1016\/j.bmcl.2025.130525_bb0065","series-title":"Long-acting N4-hydroxycytidine phosphate prodrug and its preparation method and application","author":"Hottler","year":"2024"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130525_bb0070","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1128\/AAC.48.12.4636-4642.2004","article-title":"Metabolism of the anti-hepatitis C virus nucleoside beta-D-N4-hydroxycytidine in different liver cells","volume":"48","author":"Hernandez-Santiago","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"1\u20132","key":"10.1016\/j.bmcl.2025.130525_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/07328319708002521","article-title":"Convenient intermediates for the preparation of C-4 modified derivatives of pyrimidine nucleosides","volume":"16","author":"Miah","year":"1997","journal-title":"Nucleosides Nucleotides"},{"issue":"43","key":"10.1016\/j.bmcl.2025.130525_bb0080","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1002\/ejoc.202001340","article-title":"A high-yielding synthesis of EIDD-2801 from uridine","volume":"2020","author":"Steiner","year":"2020","journal-title":"Eur J Org Chem"},{"issue":"16","key":"10.1016\/j.bmcl.2025.130525_bb0085","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1021\/jo00251a010","article-title":"Synthesis and spectroscopic analysis of branched RNA fragments: messenger RNA splicing intermediates","volume":"53","author":"Damhat","year":"1988","journal-title":"J Org Chem"},{"issue":"28","key":"10.1016\/j.bmcl.2025.130525_bb0090","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1002\/chem.201801083","article-title":"UDP-GlcNAc analogues as inhibitors of O-GlcNAc transferase (OGT): spectroscopic, computational, and biological studies","volume":"24","author":"Ghirardello","year":"2018","journal-title":"Chem Eur J"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25004342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25004342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:22:40Z","timestamp":1781943760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25004342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":18,"alternative-id":["S0960894X25004342"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130525","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and antiviral activity evaluation of the bis-ester prodrug of N4-hydroxycytidine phosphate","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130525"}}